Clinical Trial Update: Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating adjuvant proton therapy or IMRT for bladder cancer has completed (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma of the Bladder

Drugs mentioned

• IMRT
• Proton therapy

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Urothelial Carcinoma of the Bladder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-11-26